Working memory: Neuropsychological and neurobiological issues;Pamiȩć operacyjna: Zagadnienia neuropsychologiczne i neurobiologiczne

Psychiatria Polska

Volumn 40, Issue 3, 2006, Pages 383-399

  Borkowska, Alina ^a   Wiłkość, Monika ^a   Tomaszewska, Marta ^a   Rybakowski, Janusz ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Poznan University of Medical Sciences   (Poland)

Author keywords

Molecular genetic; Neuropsychology; Working memory

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTRANSMITTER;

BRAIN; GENETIC POLYMORPHISM; MEDICAL RESEARCH; MOLECULAR GENETICS; NEUROBIOLOGY; NEUROPSYCHOLOGY; REVIEW; WORKING MEMORY; BIPOLAR DISORDER; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SHORT TERM MEMORY;

BIPOLAR DISORDER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA;

EID: 33747438016     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Baxter RD, Liddle PF. Neuropsychological deficits associated with schizophrenic syndromes. Schizophr. Res. 1998; 30 (3): 239-249.
2. Baddeley A. The episodic buffer: a new component of working memory? Trends Cogn. Sc. 2000; 4 (11): 417-423.
3. Swanson H. What develops in working memory? A life span perpective. Dev. Psychol. 1999; 35 (4): 986-1000.
4. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtis G, red. Wisconsin Card Sorting Test manual. Psychological Assessment Resources. Odessa Florida, USA: 1993.
5. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Neuropsychology Press; 1985.
6. Coppola, R. Working Memory Test V1.06.1. Clinical Brain Disorder Branch, NIMH, 1999.
7. Stroop JR. Studies of interference in serial verbal reaction. J. Exp. Psychol. 1935; 18: 643-662.
8. D'Esposito M, Postle BR. Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp. Brain Res. 2000; 133 (1), 3-11.
9. Hartman M, Stekettee MC, Silva S, Lanning K, McCann H. Working memory and schizophrenia: evidence for slowed encoding. Schizophr. Res. 2002, 59, 99-113.
10. Hutton S, Puri B, Duncan J, Robbins T, Barnes T, Joyce E. Executive function in first-episode schizophrenia. Psychol. Med. 1998; 28: 463-437.
11. Mohamed S, Fleming S, Penn DL, Spanding W. Insight in schizophrenia: its relationship to measures of executive functions. J. Nerv. Ment. Dis. 1999; 187 (9): 525-531.
12. Berman KF, Doran AR, Pickar D, Weinberger R. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Brit. J. Psychiatry 1993; 162: 183-192.
13. Carter CS, Robertson LC, Nordahl TE, Chaderjian M, Oshora-Celaya L. Perceptual and attentional asymmetries in schizophrenia: further evidence for a left hemisphere deficit. Psychiatry Res. 1998, 62, 111-119.
14. nd Annual Meeting, December 7-11, 2003, San Juan, Puerto Rico. Scientific abstracts, s. 242.
15. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn J, Frank J, Berman KF, Weinberger DR. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am. J. Psychiatry 2000; 157: 26-33.
16. Hoff AL, Kremen W. Is there a cognitive phenotype for schizophrenia: the nature and course of the disturbance in cognition? Curr. Opin. Psychiatry 2002; 15: 43-48.
17. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE. Effect of COMT Val 108/158 Met phenotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sc. USA 2001; 98: 6917-6922.
18. Rybakowski J, Borkowska A. Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patiens. Schizophr. Res 2002, 54: 105-110.
19. Rybakowski J, Borkowska A, Czerski PM, Skibińska M, Hauser J. Polymorphism of the brain-derived neurotropic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bip. Dis. 2003; 5: 468-472.
20. Borkowska A, Pilaczyńska E, Rybakowski J. The frontal lobe neuropsychological tests in patients with schizophrenia and/or obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosc. 2003; 15 (3): 359-362.
21. Fossati P, Allistair JF, Ergis AM. Problem solving abilities in unipolar depression: comparison of performance on the modified version of Wisconsin and the California sorting tests. Psychiatry Res. 2001; 104: 145-156.
22. Balanza-Martinez V, Tabares-Seisdedos R, Selva-Vera G, Martinez-Aran A, Torrent C, Salazar-Fraile J, Leal-Cercos C, Vieta E, Gomez-Beneyto M. Persistent cognitive dysfunctions in bipolar 1 disorder and schizophrenic patients: a 3-year follow-up study. Psychother. Psychosom. 2005; 74 (2): 113-119.
23. Borkowska A, Rybakowski J. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bip. Disord. 2001, 3: 88-94.
24. McIntosh AM, Harrison LK, Forrester K, Lawrie SM, Johnstone EC. Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Brit. J. Psychiatry 2005; 186: 378-385.
25. Clark L, Kempton MJ, Scarna A, Grasby PM, Goodwin GM. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol. Psychiatry 2005; 57 (2): 183-187.
26. Zalla T, Joyce C, Szoke A, Schurhoff F, Pillon B, Komano O, Perez-Diaz F, Bellivier F, Alter C, Dubois B, Rouillon F, Houde O, Leboyer M. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res. 2004; 121 (3): 207-217.
27. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bip. Dis. 2004; 6: 171-182.
28. Henson R. Neural working memory. W: Andrade J, red. Working memory in perspective. Psychology Press; 2001; 151-173.
29. Owen AM. Cognitive planning in humans: neuropsychological, neuroanatomical and neuropharmalogical perspective. Progr. Neurobiol. 1997; 53 (4), 431-450.
30. Rowe JB, Toni I, Josephs O, Frackowiak RSJ, Passingham R. The prefrontal cortex: response selection or maintenance within working memory? Science 2000; 1656-1660.
31. Awh E, Jonides J, Smith EE, Schmacher EH, Koeppe RA, Katz S. Dissociation of storage and rehearsal in verbal working memory. Psychol. Sc. 1996; 7: 25-31.
32. Besner D. Phonology, lexical access in reading and articulatory suppression: A critical review. Quart. J. Exp. Psychol. 1987; 39 (3): 467-478.
33. Goldman-Rakic P. Circuity of primate prefrontal cortex and regulation of behavior by representational memory. Hanbook of physiology, the nervous system, functions of the brain. Am. Phys. Soc. 1987: 373-417.
34. Curtis CE, D'Esposito M. Persistent activity in the prefrontal cortex during working memory. Trends Cogn. Sc. 2003; 7: 415-422.
35. Jonides J, Smith EE, Koeppe RA, Awh E, Minoshima S, Mintum M. Spatial memory in humans as revealed by PET. Nature 1993; 363: 623-625.
36. Frith CD, Fristo KJ, Liddle PF, Frackowiak RSJ. Willed action and the prefrontal cortex in men: a study with PET. Proc. Royal Soc. London 1991; 244: 241-246.
37. Walter H. No hypofrontality, but absence of prefrontal lateralization comparing verbal and spatial working memory in schizophrenia. Schizophr. Res. 2003; 61 (2-3), 175-184.
38. Duncan J, Owen AM. Common regions of the human prefrontal lobe recruited by diverse cognitive demands. Trends Neurosc. 2000; 23: 475-483.
39. Goldman-Rakic P. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory. Psychopathol. Brain 1991; 14: 1-17.
40. Selemon LD, Mrzljak J, Kleiman J, Herman MM, Goldman-Rakic PS. Selective neuropil deficit in prefrontal area 9, not Broca's area 44, in a new cohort of schizophrenic brains. Soc. Neurosc. Abstr. 1999; 25: 574.
41. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Somal size of cortical pyramidal neurons in schizophrenia: differential effects across neuronal populations. Biol. Psychiatry 2003; 54 (2): 111-120.
42. Rajkowska G, Halaris A, Selemon LD. Prefrontal cell pathology distinguishes bipolar disorder from schizophrenia. Biol. Psychiatry 2000; 47: 124.
43. Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN. Celebral white matter lesions in bipolar affective disorder: relationship to outcome. J. Psychiatry 2001; 178: 172-176.
44. Schlösser R, Gesierich T, Kaufman B, Vucurevic G, Hunsche S, Gawehn J, Stoeter P. Altered effective connectivity during working memory performance in schizophrenia: study with fMRI and structural equation modering. Neuro Image 2003; 19: 751-763.
45. Goldman-Rakic P. D(1) receptors in prefrontal cells and circuits. Brain Res. Rev. 2000; 31: 295-301.
46. Carr DB, Sesack SR. Hippocampal afferents to the rat prefrontal cortex: Synaptic target and relation to dopamine terminals. J. Comp. Neurol. 1996; 369: 1-15.
47. Gurden H, Tassin JP, Jay TM. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentation. Neurosc. 1999; 94: 1019-1027.
48. Williams V, Goldman-Rakic P, Castner S, Svensson T, Siever L. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacol. 1995.
49. Carlsson A, Wateres N, Carlsson M. Neurotranssmitter interactions in schizophrenia-therapeutic implications. Eur. Arch. Psychiatry Clin. Neurosc. 1999; 249 (10): 37-43.
50. Roth B. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacol. 2004; 174 (1): 17-24.
51. Dean B. Serotonin 2 receptors and the serotonin transporter in the schizophrenic brain. Behav. Brain Res. 1996; 73 (1-2): 169-175.
52. Nocjar C. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neurosc. 2002; 111 (1): 163-176.
53. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacol. 1999; 38(8): 1083-1152.
54. Arnsten AF, Goldman-Rakic PS. Alpha 2-adrenergic mechanism in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 1985, 230 (4731): 1273-1276.
55. Franowicz JS, Arnsten AF. Actions of alpha-2 noradrenergic agonist on spatial working memory and blood pressure in rhesus monkeys appear to be mediated by the same receptor subtype. Psychopharmacol. 2002, 162 (3): 304-312.
56. Mazure CM. Does stress cause psychiatric illness? Progr. Psychiatry 1995; 270.
57. Maron J, Brockington A, Wise R, Rocha B, Hope B. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of dopamine transporter: Evidence from knock-out mouse lines. J. Neurosc. 2002; 22 (2): 389-395.
58. Pochwik P, Davidson M, Hurontunian V, Gabriel SM, Purohit DP, Pearl DP, Harvey PD, Davis KL. Postmortem studies in schizophrenia. Schizophr. Bull. 1998; 24: 325-341.
59. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NC, Nathanson NM, Silva AJ. Selective cognitive dysfunction in acetyloholine M1 muscarinic receptor mutant mice. Neurosc. 2003; 6: 51-58.
60. Crook JM, Tomascovic-Crook E, Copolov DL, Dean B. Low muscarinic receptor binding in prefrontal cortex from subject with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am. J. Psychiatry 2002; 158: 918-925.
61. Dean B, McLeod M, Keriakous D, McKenzie J, Scarr E. Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 2002; 1: 54-58.
62. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex in patients with schizophrenia. Mol. Psychiatry 2003; 8 (6): 592-610.
63. Waterworth DM, Basset AS, Brzustowicz LM. Recent advances in the genetics of schizophrenia. Cell. Mol. Life Sc. 2002; 59 (2): 331-348.
64. McGuffin P, Tandon K, Corsico A. Linkage and association studies of schizophrenia. Curr. Psychiatry Rep. 2003; 5 (2): 121-127.
65. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak- Wȩglarz M, Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J. Neural. Transm. 2005; publikacja on line: DOI 10.1007/s00702-005-0292-6.
66. Van Ness SH, Owens MJ, Kitts CD. The 3′VNTR element in dat 1 regulates in vitro DAT binding site density. Biol. Psychiatry 2004; 55: 34.
67. Rybakowski JK, Borkowska A, Czerski PM, Dmitrzak-Wȩglarz M, Skibińska M, Kapelski P, Hauser J. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes for dopaminergic inactivation. Psychiatry Res. 2005 [w druku].
68. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski C, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogen. 1996; 6: 243-250.
69. Peralta V. Can schizophrenia be diagnosed in the initial prodromal phase? Arch. Gen. Psychiatry 2002; 59 (7): 664-665.
70. Malhotra AK. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 2002; 159 (4): 652-654.
71. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X i in. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry 2002; 52: 701-707.
72. Rybakowski JK, Borkowska A, Skibińska M, Szczepankiewicz A, Kapelski P, Leszczyńska-Rodziewicz A, Czerski PM, Hauser J. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the BDNF gene. Psychiatry Clin. Neurosc. 2005 [w druku].
73. nd Annual Meeting, December 7-11, 2003, San Juan, Puerto Rico. Scientific abstracts, s. 246.
74. Egan M, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR i in. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Nat. Acad. Sc. USA 2004; 101: 12604-12609.
75. Egan M, Kojima M, Callicot JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.